MDM4 expression in wtTP53-tumors is actually a potential indication forTP53reactivation cancer therapy by simultaneous focusing on ofMDM4andMDM2
MDM4 expression in wtTP53-tumors is actually a potential indication forTP53reactivation cancer therapy by simultaneous focusing on ofMDM4andMDM2. restoration, and senescence [1-4]. Approximately half of human cancers have mutations in theTP53gene [5], indicating thatTP53inactivation is pivotal in cancer development. The remaining cancers retain the wild-type (wt) status ofTP53, which is inhibited by deregulated upstream modulators and/or… Read More: MDM4 expression in wtTP53-tumors is actually a potential indication forTP53reactivation… »